CIAPIN1作为促进口腔状细胞癌进展的促进剂
Shan Yang1, Changsheng Sun1, Zhikai Fang1
1The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People's Republic of China.
概括
细胞因子诱导的亡抑制剂1 (CIAPIN1) 在口腔状细胞癌 (OSCC) 中被上调,并促进其恶性进展. 击败CIAPIN1会降低OSCC细胞的活力,迁移和入侵,同时增加细胞亡.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 口腔状细胞癌 (OSCC) 是一种常见的恶性瘤,具有复杂的分子基础.
- 了解特定基因在OSCC发育中的作用对于确定治疗点至关重要.
研究的目的:
- 在OSCC中研究细胞因子诱导的亡抑制剂1 (CIAPIN1) 的表达.
- 阐明CIAPIN1在OSCC进展中的功能性作用,包括其对细胞活力,迁移,入侵,上皮-介质细胞过渡 (EMT) 和亡的影响.
主要方法:
- 在各种癌症中对CIAPIN1进行生物信息分析.
- 免疫组织化学 (IHC) 用于评估OSCC组织和健康对照中的CIAPIN1蛋白水平.
- 定量实时PCR (qRT-PCR) 和Western Blot (WB) 用于确定OSCC细胞系中的CIAPIN1mRNA和蛋白质表达.
- 在体外功能测试 (MTT, scratch, transwell,流动细胞计, WB) 评估CIAPIN1对OSCC细胞行为和EMT标记物的作用.
主要成果:
- CIAPIN1在多种瘤中表现异常,与健康样本相比,OSCC组织中观察到显著的上调 (p < 0.001).
- 与正常HOK细胞相比,OSCC细胞系 (CAL-27,SAS,SCC9) 的CIAPIN1mRNA和蛋白质水平显著升高.
- 在SAS和SCC9细胞中,CIAPIN1的淘汰导致细胞活力,迁移和入侵的降低,以及细胞亡的增加.
- 抑制CIAPIN1导致N-cadherin减少和E-cadherin表达增加,表明EMT的抑制.
结论:
- CIAPIN1在促进口腔状细胞癌的恶性进展方面发挥着重要作用.
- 在OSCC中,CIAPIN1有助于增强细胞活力,迁移,入侵和EMT.
- CIAPIN1代表了口腔状细胞癌的潜在治疗标.
更多相关视频
07:08Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.3K
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
11.5K
相关概念视频
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancer Cell Migration through Invadopodia
3.2K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
MAPK Signaling Cascades
7.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.9K
